Biotechnology and artificial intelligence in aesthetics: A new approach to melasma diagnosis

The diagnosis of melasma remains a clinical challenge due to its multifactorial nature and the subjectivity involved in visual assessment. Recent advancements in artificial intelligence (AI) and biotechnology have introduced new strategies for standardizing diagnosis, reducing interobserver variability, and optimizing treatment pathways. This article explores how AI, when integrated with biotechnology, provides a reliable and objective tool for diagnosing hyperpigmentary disorders. A novel case is presented using an AI-driven platform developed in Brazil, which utilizes image processing to calculate the Melasma Area and Severity Index (MASI), offering greater accuracy and reproducibility. The integration of such systems marks a new era in aesthetic diagnostics, promoting ethical, precise, and accessible interventions.